- Home
- VKTX vs RUN Comparison
VKTX vs RUN Comparison
Compare VKTX & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VKTX | RUN |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.0B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VKTX | RUN |
|---|---|---|
| Price | $35.70 | $10.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 20 |
| Target Price | ★ $95.86 | $18.80 |
| AVG Volume (30 Days) | 2.2M | ★ 9.8M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 113.35 |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | ★ $858,578,000.00 |
| Revenue This Year | N/A | $2.81 |
| Revenue Next Year | N/A | $4.54 |
| P/E Ratio | ★ N/A | $16.08 |
| Revenue Growth | N/A | ★ 12.97 |
| 52 Week Low | $22.96 | $9.01 |
| 52 Week High | $43.15 | $22.44 |
Technical Indicators
Market Signals| Indicator | VKTX | RUN |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 26.84 |
| Support Level | $33.65 | N/A |
| Resistance Level | $36.77 | $13.46 |
| Average True Range (ATR) | 1.86 | 0.67 |
| MACD | -0.65 | -0.24 |
| Stochastic Oscillator | 13.92 | 4.63 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.